Literature DB >> 22531505

Microarrays and cancer diagnosis.

Manjul Tiwari1.   

Abstract

Cancer can be considered a "developmental disorder" because it involves a disruption in the normal development of cells, in terms of both differentiation and proliferation (Dean M,1998). Cancer cells generally contain the full complement of biomolecules that are necessary for survival, proliferation, differentiation, cell death, and expression of cell type-specific function. Human Cancer diagnosis and classification by Microarray analysis has yet to be widely accepted despite the exponential increase in microarray studies reported in the literatures. Additionally, recent microarrays were inspired by the nucleotide-based technology, which have created to better define the molecular basis of malignancy which have shown that microarray have clinical utility in cancer diagnosis, risk stratification, and patient management.

Entities:  

Mesh:

Year:  2012        PMID: 22531505     DOI: 10.4103/0973-1482.95166

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  3 in total

1.  miRNA-218/FANCI is associated with metastasis and poor prognosis in lung adenocarcinoma: a bioinformatics analysis.

Authors:  Guanchao Ye; Yafei Liu; Lan Huang; Chunyang Zhang; Yinliang Sheng; Bin Wu; Chunli Wu; Yu Qi
Journal:  Ann Transl Med       Date:  2021-08

2.  Layered signaling regulatory networks analysis of gene expression involved in malignant tumorigenesis of non-resolving ulcerative colitis via integration of cross-study microarray profiles.

Authors:  Shengjun Fan; Zhenyu Pan; Qiang Geng; Xin Li; Yefan Wang; Yu An; Yan Xu; Lu Tie; Yan Pan; Xuejun Li
Journal:  PLoS One       Date:  2013-06-25       Impact factor: 3.240

Review 3.  An overview of the role of platelets in angiogenesis, apoptosis and autophagy in chronic myeloid leukaemia.

Authors:  Lisa Repsold; Roger Pool; Mohammed Karodia; Gregory Tintinger; Annie Margaretha Joubert
Journal:  Cancer Cell Int       Date:  2017-10-30       Impact factor: 5.722

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.